Elicio Therapeutics (ELTX) Interest Expenses (2022 - 2026)
Elicio Therapeutics (ELTX) reported Interest Expenses of $407000.0 for Q1 2026, up 131.25% on a YoY basis from $176000.0 in Q1 2025, and up 20.77% quarter-over-quarter from $337000.0 in Q4 2025.
Elicio Therapeutics (ELTX) Interest Expenses (2022 - 2026) Analysis & Trends
Elicio Therapeutics has reported Interest Expenses for 5 years, with the latest figure at $407000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 131.25% year-over-year to $407000.0; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (up 128.86% YoY), and the FY2025 full-year result was $1.1 million, up 149.01% from the prior year.
- Interest Expenses for Q1 2026 stood at $407000.0, up from $337000.0 in the prior quarter.
- The five-year high for Interest Expenses was $1.1 million in Q3 2022, with the low at $1000.0 in Q3 2023.
- Historically, Interest Expenses has averaged $330750.0 across 5 years, with a median of $214000.0 in 2024.
- Annual changes were most pronounced in 2023 — Interest Expenses sank 99.91% — and 2024, when it soared 13600.0%.
- Elicio Therapeutics' Interest Expenses stood at $92000.0 in 2022, then slumped by 97.83% to $2000.0 in 2023, then jumped by 11600.0% to $234000.0 in 2024, then soared by 44.02% to $337000.0 in 2025, then increased by 20.77% to $407000.0 in 2026.
- The last three Interest Expenses figures came in at $407000.0 (Q1 2026), $337000.0 (Q4 2025), and $426000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Elicio Therapeutics | 70.12 Mn | 55.17 Mn | - | 407,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 407,000.00 |
| Mar 31, 2026 | 407,000.00 |
| Dec 31, 2025 | 337,000.00 |
| Dec 31, 2025 | 337,000.00 |
| Sep 30, 2025 | 426,000.00 |
| Sep 30, 2025 | 426,000.00 |
| Jun 30, 2025 | 194,000.00 |
| Jun 30, 2025 | 194,000.00 |
| Mar 31, 2025 | 176,000.00 |
| Mar 31, 2025 | 176,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Jun 30, 2024 | 49,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Mar 31, 2024 | 36,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |